These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29335207)

  • 1. Synthesis and biological evaluation of 3-(2-aminoethyl) uracil derivatives as gonadotropin-releasing hormone (GnRH) receptor antagonists.
    Kim SM; Lee M; Lee SY; Lee SM; Kim EJ; Kim JS; Ann J; Lee J; Lee J
    Eur J Med Chem; 2018 Feb; 145():413-424. PubMed ID: 29335207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of SKI2670, a novel, orally active, non-peptide GnRH antagonist, on hypothalamic-pituitary-gonadal axis.
    Kim SM; Yoo T; Lee SY; Kim EJ; Lee SM; Lee MH; Han MY; Jung SH; Choi JH; Ryu KH; Kim HT
    Life Sci; 2015 Oct; 139():166-74. PubMed ID: 26321528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zwitterionic uracil derivatives as potent GnRH receptor antagonists with improved pharmaceutical properties.
    Regan CF; Guo Z; Chen Y; Huang CQ; Chen M; Jiang W; Rueter JK; Coon T; Chen C; Saunders J; Brown MS; Betz SF; Struthers RS; Yang C; Wen J; Madan A; Zhu YF
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4503-7. PubMed ID: 18667310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent and orally bioavailable zwitterion GnRH antagonists with low CYP3A4 inhibitory activity.
    Chen C; Chen Y; Pontillo J; Guo Z; Huang CQ; Wu D; Madan A; Chen T; Wen J; Xie Q; Tucci FC; Rowbottom M; Zhu YF; Wade W; Saunders J; Bozigian H; Struthers RS
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3301-5. PubMed ID: 18442910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and structure-activity relationships of 1-arylmethyl-5-aryl-6-methyluracils as potent gonadotropin-releasing hormone receptor antagonists.
    Guo Z; Zhu YF; Gross TD; Tucci FC; Gao Y; Moorjani M; Connors PJ; Rowbottom MW; Chen Y; Struthers RS; Xie Q; Saunders J; Reinhart G; Chen TK; Bonneville AL; Chen C
    J Med Chem; 2004 Feb; 47(5):1259-71. PubMed ID: 14971906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of 1-{4-[1-(2,6-difluorobenzyl)-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-3-methoxyurea (TAK-385) as a potent, orally active, non-peptide antagonist of the human gonadotropin-releasing hormone receptor.
    Miwa K; Hitaka T; Imada T; Sasaki S; Yoshimatsu M; Kusaka M; Tanaka A; Nakata D; Furuya S; Endo S; Hamamura K; Kitazaki T
    J Med Chem; 2011 Jul; 54(14):4998-5012. PubMed ID: 21657270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of sodium R-(+)-4-{2-[5-(2-fluoro-3-methoxyphenyl)-3-(2-fluoro-6-[trifluoromethyl]benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenylethylamino}butyrate (elagolix), a potent and orally available nonpeptide antagonist of the human gonadotropin-releasing hormone receptor.
    Chen C; Wu D; Guo Z; Xie Q; Reinhart GJ; Madan A; Wen J; Chen T; Huang CQ; Chen M; Chen Y; Tucci FC; Rowbottom M; Pontillo J; Zhu YF; Wade W; Saunders J; Bozigian H; Struthers RS
    J Med Chem; 2008 Dec; 51(23):7478-85. PubMed ID: 19006286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a thieno[2,3-d]pyrimidine-2,4-dione bearing a p-methoxyureidophenyl moiety at the 6-position: a highly potent and orally bioavailable non-peptide antagonist for the human luteinizing hormone-releasing hormone receptor.
    Sasaki S; Cho N; Nara Y; Harada M; Endo S; Suzuki N; Furuya S; Fujino M
    J Med Chem; 2003 Jan; 46(1):113-24. PubMed ID: 12502365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of an Orally Bioavailable Gonadotropin-Releasing Hormone Receptor Antagonist.
    Kim SM; Lee M; Lee SY; Park E; Lee SM; Kim EJ; Han MY; Yoo T; Ann J; Yoon S; Lee J; Lee J
    J Med Chem; 2016 Oct; 59(19):9150-9172. PubMed ID: 27608177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of 1-arylmethyl-3- (2-aminoethyl)-5-aryluracil as novel gonadotropin-releasing hormone receptor antagonists.
    Zhu YF; Gross TD; Guo Z; Connors PJ; Gao Y; Tucci FC; Struthers RS; Reinhart GJ; Saunders J; Chen TK; Killam Bonneville AL; Chen C
    J Med Chem; 2003 May; 46(11):2023-6. PubMed ID: 12747774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of mono- and diaminopyrimidine derivatives as novel, nonpeptide gonadotropin releasing hormone (GnRH) receptor antagonists.
    Luthin DR; Hong Y; Tompkins E; Anderes KL; Paderes G; Kraynov EA; Castro MA; Nared-Hood KD; Castillo R; Gregory M; Vazir H; May JM; Anderson MB
    Bioorg Med Chem Lett; 2002 Dec; 12(24):3635-9. PubMed ID: 12443792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationships of 1-arylmethyl-3-(2-aminopropyl)-5-aryl-6-methyluracils as potent GnRH receptor antagonists.
    Guo Z; Zhu YF; Tucci FC; Gao Y; Struthers RS; Saunders J; Gross TD; Xie Q; Reinhart GJ; Chen C
    Bioorg Med Chem Lett; 2003 Oct; 13(19):3311-5. PubMed ID: 12951116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of nonpeptide antagonist binding to the human gonadotropin-releasing hormone receptor: Implications for structure-activity relationships and insurmountable antagonism.
    Sullivan SK; Hoare SR; Fleck BA; Zhu YF; Heise CE; Struthers RS; Crowe PD
    Biochem Pharmacol; 2006 Sep; 72(7):838-49. PubMed ID: 16930559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uracils as potent antagonists of the human gonadotropin-releasing hormone receptor without atropisomers.
    Guo Z; Chen Y; Huang CQ; Gross TD; Pontillo J; Rowbottom MW; Saunders J; Struthers S; Tucci FC; Xie Q; Wade W; Zhu YF; Wu D; Chen C
    Bioorg Med Chem Lett; 2005 May; 15(10):2519-22. PubMed ID: 15863308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of linzagolix, a novel, orally active, non-peptide antagonist of gonadotropin-releasing hormone receptors.
    Tezuka M; Tamai Y; Kuramochi Y; Kobayashi K; Fushimi N; Kiguchi S
    Clin Exp Pharmacol Physiol; 2022 Oct; 49(10):1082-1093. PubMed ID: 35690889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-phenyl-4-piperazinylbenzimidazoles: orally active inhibitors of the gonadotropin releasing hormone (GnRH) receptor.
    Pelletier JC; Chengalvala M; Cottom J; Feingold I; Garrick L; Green D; Hauze D; Huselton C; Jetter J; Kao W; Kopf GS; Lundquist JT; Mann C; Mehlmann J; Rogers J; Shanno L; Wrobel J
    Bioorg Med Chem; 2008 Jul; 16(13):6617-40. PubMed ID: 18511284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-[(2R)-Amino-2-phenylethyl]-1-(2,6-difluorobenzyl)-5-(2-fluoro-3-methoxyphenyl)- 6-methylpyrimidin-2,4-dione (NBI 42902) as a potent and orally active antagonist of the human gonadotropin-releasing hormone receptor. Design, synthesis, and in vitro and in vivo characterization.
    Tucci FC; Zhu YF; Struthers RS; Guo Z; Gross TD; Rowbottom MW; Acevedo O; Gao Y; Saunders J; Xie Q; Reinhart GJ; Liu XJ; Ling N; Bonneville AK; Chen T; Bozigian H; Chen C
    J Med Chem; 2005 Feb; 48(4):1169-78. PubMed ID: 15715483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure-activity relationships of (R)-1-alkyl-3-[2-(2-amino)phenethyl]-5-(2-fluorophenyl)-6-methyluracils as human GnRH receptor antagonists.
    Rowbottom MW; Tucci FC; Zhu YF; Guo Z; Gross TD; Reinhart GJ; Xie Q; Struthers RS; Saunders J; Chen C
    Bioorg Med Chem Lett; 2004 May; 14(9):2269-74. PubMed ID: 15081023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a gonadotropin-releasing hormone antagonist as a physiologic probe in polycystic ovary syndrome: assessment of neuroendocrine and androgen dynamics.
    Hayes FJ; Taylor AE; Martin KA; Hall JE
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2343-9. PubMed ID: 9661606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological characterization of a novel, orally active small molecule gonadotropin-releasing hormone (GnRH) antagonist using castrated and intact rats.
    Anderes KL; Luthin DR; Castillo R; Kraynov EA; Castro M; Nared-Hood K; Gregory ML; Pathak VP; Christie LC; Paderes G; Vazir H; Ye Q; Anderson MB; May JM
    J Pharmacol Exp Ther; 2003 May; 305(2):688-95. PubMed ID: 12606616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.